Metraipolis › archive › dc_53cbf0b001ff

Serum Dysregulation of IL-36, IL-37, and IL-38 in Pyoderma Gangrenosum: Clinical Correlations and Implications for IL-36R-Targeted Therapy — Europe PMC PMID:41465501

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41465501
DOI
10.3390/ijms262412076
License (as archived)
solo-consultazione
Archived
2026-11-07T15:18:07.331Z
SHA-256 of the archived text
10da4f7a93b2d41492f7d0b6a926abcce8d52e0317803324687e7c504b805b46
Stable URL of this page
https://metraipolis.com/documento/dc_53cbf0b001ff

How to cite

Serum Dysregulation of IL-36, IL-37, and IL-38 in Pyoderma Gangrenosum: Clinical Correlations and Implications for IL-36R-Targeted Therapy — Europe PMC PMID:41465501 — Europe PMC (en), https://europepmc.org/article/MED/41465501 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_53cbf0b001ff (Metraipolis archive dc_53cbf0b001ff, sha256 10da4f7a93b2d41492f7d0b6a926abcce8d52e0317803324687e7c504b805b46)
BibTeX
@misc{dc53cbf0b001ff,
  title = {Serum Dysregulation of IL-36, IL-37, and IL-38 in Pyoderma Gangrenosum: Clinical Correlations and Implications for IL-36R-Targeted Therapy — Europe PMC PMID:41465501},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41465501},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_53cbf0b001ff; sha256 10da4f7a93b2d41492f7d0b6a926abcce8d52e0317803324687e7c504b805b46},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41465501. Agents can read the archived copy with the MCP tool read_document.